India Sampada Gosavi explains how she has led a transformation of Astellas’ operations in India to launch innovative products in oncology and women’s health, coupled with a commitment to building internal capabilities. With a ‘hypergrowth phase’ anticipated, Astellas will nevertheless need to continue to navigate India’s regulatory environment and engage in…
USA The US Food and Drug Administration has increasingly recognized the importance of diversity and representation in clinical trials over the past few decades. This evolution reflects growing awareness across medicine that differences in age, gender, race, and ethnicity can impact disease risk, treatment response, and health outcomes. Darshan Kulkarni of…
UAE Over the past few decades, the UAE has worked hard to attract top global talent to fill the gaps that its small local population was unable to. While the high salaries on offer were previously the main attractor to the country, with workers often staying for a couple of years…
USA Although clinical trial diversity remains high on the agendas of industry sponsors, there is still a long road to travel towards more equitable and representative research – and ultimately safer and more effective medicines. On this theme, writing in the June 2023 edition of the DIA Global Forum magazine, Jorge…
Greece Merck Greece’s Susan King-Barnardo outlines how she navigated the affiliate through the challenging waters of COVID-19, the unique market access challenges that innovative pharma is facing in Greece, Merck’s burgeoning clinical trial footprint in the country, and her approach to fostering diversity, equity, and inclusion. There is a lot…
MEA The healthcare and life sciences industry is well represented in Forbes Middle East’s 100 Most Powerful Businesswomen 2023 list alongside sectors such as banking, investments, and retail. In a region that is making some important advances in diversity, equity and inclusion, these five women – including two former PharmaBoardroom interviewees…
Egypt While evidence and recognition are growing that gender-balanced and diverse management teams at all levels of hierarchies produce positive business outcomes, the MENA region still has a long road to travel in this respect. Only 11 percent of senior management positions in MENA firms and just four percent of board…
Global Fortune’s new 50 Most Powerful Women in Business list features four representatives of Big Pharma, as well as a further four from powerful US health insurance corporations. The annual ranking is based on five criteria: the size and importance of a leader’s business in the global economy, the health…
USA Ramona Sequeira, recently appointed chair of the PhRMA board of directors and president of Takeda’s US Business Unit and Global Portfolio Commercialization, gives her take on how the biopharma industry can do more to address the systemic inequities in US healthcare, including community-focused grant programs, clinical trial diversity initiatives, and…
MEA On International Women’s Day 2022, Inna Nadelwais, executive director at Middle East and Africa medtech trade association Mecomed, examines the road still to travel towards true gender parity in the MEA medtech workforce, and why diversity, inclusion, and equality in the workplace benefits all parties. The MEA region continues…
Saudi Arabia Before Crown Prince Mohammed bin Salman assumed office in 2017, Saudi Arabian women had only a marginal presence in the Kingdom’s labour force. However, since then notable milestones achieved include granting women the right to drive, access to sports, a first female ambassador, freedom to travel, the right to live…
Denmark In a wide-ranging and candid conversation, Siemens Healthineers’ Tisha Boatman discusses uprooting from the US to Denmark, how Danish hospital tendering needs to evolve beyond price considerations alone, the challenges and opportunities of the Varian integration in her region, and shares some advice for other female executives in the medtech…
See our Cookie Privacy Policy Here